Harold Bernstein serves as Executive at Maze Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Harold Bernstein has executed 9 insider transactions totaling $2.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 5, 2026 involved exercising options for 412 shares valued at $0.
Harold Bernstein currently holds 337,563 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Harold Bernstein has been a net seller of MAZE stock. They have purchased $0 and sold $2.0M worth of shares.
Harold Bernstein's most recent insider trade was on Jan 5, 2026, when they sold 412 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $40.00 |
| Discretionary |
| Jan 5, 2026 | MAZE | $4.3K | Option Exercise | 412 | $10.42 | Discretionary |
| Jan 2, 2026 | MAZE | $0 | Option Exercise | 4,432 | $N/A | Discretionary |
| Jan 2, 2026 | MAZE | $179.2K | Sale | 4,432 | $40.43 | Discretionary |
| Jan 2, 2026 | MAZE | $46.2K | Option Exercise | 4,432 | $10.42 | Discretionary |
| Dec 29, 2025 | MAZE | $1.1M | Sale | 27,800 | $40.34 | Discretionary |
| Dec 29, 2025 | MAZE | $468.9K | Option Exercise | 45,000 | $10.42 | Discretionary |
| Dec 29, 2025 | MAZE | $704.0K | Sale | 17,200 | $40.93 | Discretionary |